Journal of Computer-Aided Molecular Design

, Volume 17, Issue 2–4, pp 119–127

In silico prediction of drug toxicity

  • John C. Dearden
Article

Abstract

It is essential, in order to minimise expensive drug failures due to toxicity being found in late development or even in clinical trials, to determine potential toxicity problems as early as possible. In view of the large libraries of compounds now being handled by combinatorial chemistry and high-throughput screening, identification of putative toxicity is advisable even before synthesis. Thus the use of predictive toxicology is called for. A number of in silico approaches to toxicity prediction are discussed. Quantitative structure-activity relationships (QSARs), relating mostly to specific chemical classes, have long been used for this purpose, and exist for a wide range of toxicity endpoints. However, QSARs also exist for the prediction of toxicity of very diverse libraries, although often such QSARs are of the classification type; that is, they predict simply whether or not a compound is toxic, and do not give an indication of the level of toxicity. Examples are given of all of these. A number of expert systems are available for toxicity prediction, most of them covering a range of toxicity endpoints. Those discussed include TOPKAT, CASE, DEREK, HazardExpert, OncoLogic and COMPACT. Comparative tests of the ability of these systems to predict carcinogenicity show that improvement is still needed. The consensus approach is recommended, whereby the results from several prediction systems are pooled. It is simply amazing that we can formulate any kind of QSAR. The (desiredactivity) is only the starting point. The truly formidable problem is that oftoxicity, especially the difficult long-term toxicities resulting from chronicusage''. (Hansch & Leo [1])

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hansch, C. and Leo, A., Exploring QSAR: Fundamentals and Applications in Chemistry and Biology, Amer. Chem. Soc., Washington, DC, 1995.Google Scholar
  2. 2.
    Kennedy, T., Drug Disc. Today, 2 (1997) 436.Google Scholar
  3. 3.
    Crum Brown, A. and Fraser, T.R., Trans. Roy. Soc. Edinburgh, 25 (1868-69) 151.Google Scholar
  4. 4.
    Hansch, C., Maloney, P.P., Fujita, T. and Muir, R.M., Nature, 194 (1962) 178.Google Scholar
  5. 5.
    Hansch, C. and Clayton, J.M., J. Pharm. Sci., 62 (1973) 1.Google Scholar
  6. 6.
    King, L.A. and Moffat, A.C., Med. Sci. Law, 23 (1983) 193.Google Scholar
  7. 7.
    Lien, E.J. and Tong, G.L., Cancer Chemother. Rep., 57 1973)Google Scholar
  8. 8.
    Jarzebski, A., Falkowski, L. and Borowski, E., J. Antibiot. 35 (1982) 220.Google Scholar
  9. 9.
    Chen, P., Cheng, P.T.W., Alam, M., Beyer, B.D., Bisacchi, G.S., Dejneka, T., Evans, A.J., Greytok, J.A., Hermsmeier, M.A., Humphreys, W.G., Jacobs, G.A., Kocy, O., Lin, P.-F., Lis, K.A., Marella, M.A., Ryono, D.E., Sheaffer, A.K., Spergel, S.H., Sun, C., Tino, J.A., Vite, G., Colonno, R.J., Zahler, R. and Barrish, J.C., J. Med. Chem., 39 (1996) 1991.Google Scholar
  10. 10.
    Schön, U., Antel, J., Brückner, R. and Messinger, J., Med. Chem., 41 (1998) 318.Google Scholar
  11. 11.
    Dearden, J.C., Cronin, M.T.D. and Thomas, G.R., J. Pharm. Pharmacol., 51 (1999) Suppl., 267.Google Scholar
  12. 12.
    Dearden, J.C., Cronin, M.T.D. and Shah, S. J. Pharm. Pharmacol., 51 (1999) Suppl., 266.Google Scholar
  13. 13.
    Hansch, C., Bjorkroth, J.P. and Leo, A., J. Pharm. Sci., 76 (1987) 663.Google Scholar
  14. 14.
    Martin, Y.C. and Hansch, C., J. Med. Chem., 14 (1971) 777.Google Scholar
  15. 15.
    Mannhold, R. and Dross, K., Quant. Struct.-Act. Relat., 15 (1996) 403.Google Scholar
  16. 16.
    Dearden, J.C., Netzeva, T.I. and Bibby, R., J. Pharm. Pharmacol. 54 (2002) suppl., S–65.Google Scholar
  17. 17.
    Dearden, J.C., Netzeva, T.I. and Bibby, R., J. Pharm. Pharmacol. 54 (2002) suppl., S–66.Google Scholar
  18. 18.
    Benigni, R. and Giuliani, A., Med. Res. Rev., 16 (1996) 267.Google Scholar
  19. 19.
    Dearden, J.C., Cronin, M.T.D., Patel, H. and Raevsky, O.A., J. Pharm. Pharmacol., 52 (2000) Suppl., 221.Google Scholar
  20. 20.
    Dearden, J.C. and Scott, A.C., J. Pharm. Pharmacol., 54 (2002) Suppl., S–66.Google Scholar
  21. 21.
    Mumtaz, M.M., Knauf, L.A., Reisman, D.J., Peirano, W.B., Derosa, C.T., Gombar, V.K., Enslein, K., Carter, J.R., Blake, B.W., Huque, K.I. and Ramanujam, V.M.S., Toxicol. Lett., 79 (1995) 131.Google Scholar
  22. 22.
    Barratt, M.D., ATLA, 23 (1995) 111.Google Scholar
  23. 23.
    Gao, H., Williams, C.M., Labute, P. and Bajorath, J., J. Chem. Inf. Comput. Sci., 39 (1999) 164.Google Scholar
  24. 24.
    Dearden, J.C. and Cronin, M.T.D., In Peijnenburg, W.J.G.M. and Damborský, J. (Eds.) Biodegradability Prediction, Kluwer Academic Publishers, Dordrecht, 1996, pp. 93-104.Google Scholar
  25. 25.
    Dearden, J.C., Barratt, M.D., Benigni, R., Bristol, D.W., Combes, R.D., Cronin, M.T.D., Judson, P.N., Payne, M.P., Richard, A.M., Tichý, M., Worth, A.P. and Yourick, J.J., ATLA, 25 (1997) 223.Google Scholar
  26. 26.
    Benfenati, E. and Gini, G., Toxicol., 119 (1997) 213.Google Scholar
  27. 27.
    Richard, A.M., Knowledge Eng. Rev., 14 (1999) 307.Google Scholar
  28. 28.
    Helma, C., Gottmann, E. and Kramer, S., Stat. Methods Med. Res., 9 (2000) 329.Google Scholar
  29. 29.
    Greene, N., Adv. Drug Deliv. Rev., 54 (2002) 417.Google Scholar
  30. 30.
    Enslein, K., Gombar, V.K. and Blake, B.W., Mut. Res., 305 (1994) 47.Google Scholar
  31. 31.
    Enslein, K., Gombar, V.K., Blake, B.W., Maibach, H.I., Hostynek, J.J., Sigman, C.C. and Bagheri, D., Food Chem. Toxicol., 35 (1997) 1091.Google Scholar
  32. 32.
    Rosenkranz, H.S., Cunningham, A.R., Zhang, Y.P., Claycamp, H.G., Macina, O.T., Sussman, N.B., Grant, S.G. and Klopman, G., SAR QSAR Environ. Res., 10 (1999) 277.Google Scholar
  33. 33.
    Cunningham, A.R., Klopman, G. and Rosenkranz, H.S., Mut. Res. - Fund. Mol. Mech. Mut., 405 (1998) 9.Google Scholar
  34. 34.
    Gomez, J., Macina, O.T., Mattison, D.R., Zhang, Y.P., Klopman, G. and Rosenkranz, H.S., Teratol., 60 (1999) 190.Google Scholar
  35. 35.
    Matthews, E.J. and Contrera, J.F., Regul. Toxicol. Pharmacol., 28 (1998) 242.Google Scholar
  36. 36.
    Greene, N., Judson, P.N., Langowski, J.J. and Marchant, C.A., SAR QSAR Environ. Res., 10 (1999) 299.Google Scholar
  37. 37.
    Steger-Hartmann, T., Yih, T.D., Marchant, C.A. and Langowski, J.J., Naunyn-Schmiedeberg's Arch. Pharmacol., 363 (2001) Suppl., S–363.Google Scholar
  38. 38.
    Barratt, M.D., Castell, J.V., Miranda, M.A. and Langowski, J.J., J. Photochem. Photobiol. B - Biol., 58 (2000) 54.Google Scholar
  39. 39.
    Smithing, M.P. and Darvas, F., In Finlay, J.W., Robinson, S.F. and Armstrong, D.J., (Eds.) Food Safety Assessment (American Chemical Society Symposium Series No. 484), American Chemical Society, Washington, DC, 1992, pp. 191-200.Google Scholar
  40. 40.
    Brown, S.J., Raja, A.A. and Lewis, D.F.V., ATLA, 22 (1994) 482.Google Scholar
  41. 41.
    Woo, Y.-T., Lai, D., Argus, M. and Arcos, J., Toxicol. Lett., 79 (1995) 219.Google Scholar
  42. 42.
    Purdy, R., Environ. Health Perspect., 104 (1996) 1085.Google Scholar
  43. 43.
    Parke, D.V., Ioannides, C. and Lewis, D.F.V., ATLA, 18 (1990) 91.Google Scholar
  44. 44.
    Lewis, D.F.V., Ioannides, C. and Parke, D.V., Drug Metab. Rev., 30 (1998) 709.Google Scholar
  45. 45.
    Lewis, D.F.V., J. Chem. Tech. Biotech., 76 (2001) 237.Google Scholar
  46. 46.
    Lewis, D.F.V., Ioannides, C. and Parke, D.V., Mut. Res., 291 (1993) 61.Google Scholar
  47. 47.
    Richard, A.M., Mut. Res. - Fund. Mol. Mech. Mutagen., 400 (1998) 493.Google Scholar
  48. 48.
    Lewis, D.F.V., Bird, M.G. and Jacobs, M.N., Human Exper. Toxicol., 21 (2002) 115.Google Scholar
  49. 49.
    Benigni, R., Mut. Res. - Environ. Muta., 334 (1995) 103.Google Scholar
  50. 50.
    Richard, A.M. and Benigni, R., SAR QSAR Environ. Res., 13 (2002) 1.Google Scholar
  51. 51.
    Benigni, R., Mut. Res. - Rev. Mut. Res., 387 (1997) 35.Google Scholar
  52. 52.
    Leo, A., Panthananickal, A. and Hansch, C., J. Med. Chem., 24 (1981) 859.Google Scholar
  53. 53.
    Topliss, J.G. and Costello, R.J., J. Med. Chem., 15 (1972) 1066.Google Scholar
  54. 54.
    Dunn, W.J. and Wold, S., J. Med. Chem., 21 (1978) 1001.Google Scholar
  55. 55.
    Rippmann, F., Quant. Struct.-Act. Relat., 9 (1990) 1.Google Scholar
  56. 56.
    Benigni, R., Giuliani, A., Franke, R. and Gruska, A., Chem. Rev., 100 (2000) 3697.Google Scholar
  57. 57.
    Benigni, R., Andreoli, C. and Giuliani, A., Carcinogenesis, 10 (1989) 55.Google Scholar
  58. 58.
    Jurs, P.C., Chou, J.T. and Yuan, M, J. Med. Chem., 22 (1979) 476.Google Scholar
  59. 59.
    Gini, G., Lorenzini, M., Benfenati, E., Grasso, P. and Bruschi, M., J. Chem. Inf. Comput. Sci., 39 (1999) 1076.Google Scholar
  60. 60.
    Zhang, L.T., Sannes, K., Shusterman, A.J. and Hansch, C., Chem.-Biol. Interact., 81 (1992) 149.Google Scholar
  61. 61.
    Blake, B.W., Enslein, K., Gombar, V.K. and Borgstedt, H.H., Mut. Res., 241 (1990) 261.Google Scholar
  62. 62.
    Moriguchi, I., Hirano, H. and Hirono, S., Environ. Health Perspect., 104 (1996) 1051.Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • John C. Dearden
    • 1
  1. 1.School of Pharmacy and ChemistryLiverpool John Moores UniversityLiverpoolEngland

Personalised recommendations